XTALKS WEBINAR: Sarcopenia: Changes and Challenges in Body Composition with GLP-1 Receptor Agonist-based Weight Loss Therapies Live and On-Demand: Friday, September 6, 2024 , at 10am EDT (4pm CEST / EU-Central) Register for this free webinar to learn about the latest clinical trial data on GLP-1 receptor agonist-based therapies and their impact on weight loss and body composition
Anticipating Volume Loss in High-Risk Patients Preventive intervention is key when prescribing semaglutide to patients with low baseline facial fat or high aesthetic concern
This is an interesting study linking the GLP1-RAs to acne, but I havent come across any patients yet, on these drugs who are getting acne, she told Dermatology Republic
Regular updates on product availability and advancements in GLP-1 therapy are essential for making informed decisions about your health.
White-label solutions often lack transparency in ingredient sourcing, third-party testing, and quality assurance, which are factors that are critical for building consumer trust
